3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
CNS
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Urinary Bladder Neoplasms
1
Signs and Symptoms
1
Postoperative Complications
1
Pathologic Processes
1
Pain, Postoperative
1
Pain
1
Neurologic Manifestations
1
Interventions
Analgesia
6
Zoledronic Acid
5
Prednisone
4
Docetaxel
4
Radiotherapy
3
cabozantinib
2
Psychiatric Rehabilitation
2
Mitoxantrone
2
Lidocaine
2
Filgrastim
2
Cystoscopy
2
tandutinib
1
strontium chloride
1
pegfilgrastim
1
Vitamin D
1
Vertebroplasty
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Strontium-89
1
Samarium-153
1
Radium-223
1
Radiation
1
Oxygen
1
Observation
1
Nitrous Oxide
1
Morphine
1
Midazolam
1
Methadone
1
Mepivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Methadone
×
Genitourinary
×
Clear all
NCT04475029
2023-09-13
METAMORF
University of Aarhus
Phase NA
Completed
114 enrolled